4.5 Article

Exploring the surface epitope and nuclear localization analysis of porcine circovirus type 3 capsid protein

Journal

AMB EXPRESS
Volume 13, Issue 1, Pages -

Publisher

SPRINGER
DOI: 10.1186/s13568-023-01652-6

Keywords

Porcine circovirus 3; Capsid protein; Monoclonal antibody; Nuclear localization; Cytotoxicity; Virus-like particle

Ask authors/readers for more resources

This study generated a monoclonal antibody specific to the capsid protein of PCV3, which can be used for diagnosis and pathogenesis studies. A novel linear B-cell epitope and a potential nuclear localization signal in the capsid protein were identified. Recombinant proteins self-assembled into virus-like particles (VLPs) with correct conformation and specificity, providing insights for the development of diagnostic tools and potential vaccines for PCV3.
Porcine circovirus 3 (PCV3) is a newly emerging virus associated with porcine dermatitis and nephropathy syndrome (PDNS) and reproductive disorders, impacting global pig populations. Porcine circoviruses contain two major open reading frames (ORFs), and the ORF2 encodes the viral capsid protein (Cap). Cap is the most antigenic structural protein and an ideal candidate for the development of vaccines and diagnostic reagents. This study generated a monoclonal antibody (MAb) specific to PCV3 Cap, MAb CCC160, for diagnosis and pathogenesis studies of this novel virus. The MAb specifically recognized PCV3-infected swine lymph node tissue in an immunohistochemical analysis confirming its clinical diagnostic potential. In addition, a novel linear B-cell epitope recognized by MAb CCC160 was identified at the amino acid region 120-134 of Cap. Nuclear localization analysis of PCV3 Cap revealed a potential nuclear localization signal (NLS) in the middle region (aa 131-143) in addition to the dominant N-terminal NLS that is already known. A cell viability assay further demonstrated that the cytotoxicity of PCV3 Cap is correlated with its nuclear localization, indicating a crucial role of Cap in the pathogenic mechanism of PCV3. A full-length construct of PCV3 Cap was successfully expressed using a baculovirus expression system and purified recombinant proteins self-assembled into virus-like particles (VLPs). The protein constitution of the VLPs was confirmed by MAb CCC160 recognition, indicating the correct conformation and specificity of VLP and exhibiting the linear epitope aa 120-134 on the VLP surface. These results provide insights for developing diagnostic tools and potential VLP vaccines for PCV3, revealing its pathogenesis and antigenic properties.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available